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INTRODUCTION
Toxocariasis is a helminthozoonosis caused by ascarid larvae 
of the Toxocara genus.
1 It is the most common helminthiasis in 
industrialized countries,
1 including Korea.
2 Human toxocariasis 
is caused by geophagia (pica), close contact with dogs or cats, 
poor personal hygiene, ingestion of contaminated raw vegeta-
bles, or ingestion of raw meat from a paratenic host.
1,3,4 As the 
rate of pet ownership in Korea increases, a concomitant increase 
in the risk for contracting toxocariasis will require physicians to 
become familiar with the clinical features and treatment of this 
disease. Toxocara infection may present with various symptoms 
affecting different organs.
1,3 Dermatologically, toxocariasis may 
be associated with pruritus, rash, and chronic urticaria, with very 
few reports of acute urticaria.
1,3,5 Toxocariasis is typically treated 
easily with albendazole,
1,3 and recurrent disease has not been 
reported in Korea. Here, we report a case of recurrent toxocari-
asis accompanied by abdominal pain and urticaria that was re-
sistant to routine treatment.
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CASE REPORT
A 35-year-old male visited our emergency room because of 
cramping epigastric pain; he had no past medical history of this 
kind. Although the patient had previously consumed raw fish, 
his most recent ingestion of potentially contaminated food was 
raw cow liver, 3 weeks prior to presentation. The patient’s blood 
pressure was 130/70 mmHg; his heart rate was 75/minutes; and 
his body temperature was 36°C. Blood analyses showed pe-
ripheral eosinophilia (leukocytes, 13.11×10
3/μL, with 58.6% 
neutrophils, 22.4% lymphocytes, 4.9% monocytes, and 12.3% 
eosinophils), an aspartate aminotransferase level of 19 U/L, 
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Human toxocariasis is the most prevalent helminthiasis in Korea and other industrialized countries. The clinical features of toxocariasis are diverse, 
according to the involved organ. Typically, Toxocara spp. infection is easily treated with 400 mg albendazole twice a day for 5 days. However, we ex-
perienced a case of recurrent toxocariasis that was refractory to this standard therapy and presented with urticaria, an uncommon symptom in toxo-
cariasis. A 35-year-old male visited our emergency room because of abdominal pain. He had recently consumed raw cow liver (3 weeks prior to pre-
sentation). Laboratory analyses revealed eosinophilia (1,612 cells/μL) and increased total IgE (3,060 IU/mL). Chest X-ray showed multiple lung nod-
ules in both lungs, and computed tomography revealed multiple ground-glass opacities in both lungs and multiple tiny liver abscesses. Liver biopsy 
revealed an eosinophilic abscess. Enzyme-linked immunosorbent assay findings for Toxocara antigens were positive (optical density, 2.140), leading 
to a diagnosis of toxocariasis. We initiated a 5-day treatment with albendazole and prednisolone; however, 6 days after completing the treatment, 
the patient again experienced urticaria and severe itching that could not be controlled by antihistamines or hydrocortisone cream. A second bout of 
eosinophilia suggested recurring toxocariasis, for which we prescribed a second round of albendazole. Despite an initial improvement in his symp-
toms, the patient returned after 6 weeks complaining of abdominal pain for 6 hours, which was reminiscent of his first attack; he also exhibited eo-
sinophilia. Accordingly, albendazole was administered once more for an additional 3 weeks, and his symptoms resolved.
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Fig. 3.  Patchy and dense eosinophilic infiltration in liver biopsy (H&E stain, A: ×200, B: ×400).
Fig. 2.  Multiple ground-glass opacities in both lungs in chest CT.
Fig. 1.  Multiple tiny liver abscesses in abdomen CT.
A B
and an alanine aminotransferase level of 17 U/L. The patient 
tested negative for HBsAg and anti-HCV antibody, and positive 
for anti-HBs antibody. Prothrombin time and activated partial 
thromboplastin time were normal. The patient’s level of C-re-
active protein was normal at 0.16 mg/dL (0–0.5 mg/dL). Urinal-
ysis and stool examination revealed no abnormalities. The pa-
tient’s serum total immunoglobulin (Ig) E level was 3,060 IU/
mL, as determined using a paper radioimmunsorbent test. 
Physical examination revealed tenderness in the epigastric 
area. Although no abnormality was observed upon abdominal 
X-ray, chest X-ray revealed multiple nodules in both lungs, and 
abdominal and chest computed tomography revealed multiple 
tiny liver abscesses (Fig. 1) and multiple ground-glass opaci-
ties in both lungs (Fig. 2). Liver biopsy showed patchy, dense 
eosinophilic hepatic infiltrates, suggestive of eosinophilic ab-
scess (Fig. 3). Bone marrow biopsy revealed normocellular A Case of Recurrent Toxocariasis With Urticaria AAIR 
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marrow with increased eosinophils. Gastroscopy at the time of 
epigastric pain showed no evidence of other parasitic infections 
such as anisakiasis. When we measured Toxocara canis larva 
E/S antigen-specific IgG using an enzyme-linked immunosor-
bent assay kit (TES-ELISA; Bordier Affinity Products SA, Crissier, 
Switzerland), the observed optical density (2.140) suggested the 
presence of Toxocara larva at a relatively high titer when com-
pared against the positive (0.616) and negative (0.033) controls. 
We then initiated treatment with 400 mg albendazole twice a day 
(the patient’s weight was 80 kg) and 60 mg prednisolone for 5 
days. However, 6 days after the cessation of albendazole, the pa-
tient again experienced generalized urticaria and itching that 
could not be controlled through the use of antihistamines or 
hydrocortisone cream. The possibility of a drug allergy was con-
sidered unlikely given the lapse in time between drug treat-
ment and presentation of symptoms. Because the patient 
showed eosinophilia (increasing from 46 to 1,262 cells/μL) and 
newly developed urticaria that was refractory to conventional 
treatment, we suspected the recurrence or inadequate treat-
ment of toxocariasis. A second round of 400 mg albendazole 
once daily for 2 weeks was initiated, and this eliminated both 
urticaria and itching within 1 day. The patient was discharged 
with improved symptoms after 1 week. Six weeks after dis-
charge, the patient returned to the emergency room, again com-
plaining of cramping epigastric pain reminiscent of his first at-
tack of toxocariasis. Repeated gastroscopy revealed only chron-
ic gastritis. The laboratory test showed an elevated eosinophil 
count (increasing from 543 to 1,335 cells/μL). We suspected re-
current toxocariasis and prescribed 400 mg albendazole once 
daily. After treatment, the patient’s symptoms appeared to be 
resolved and his eosinophil count had normalized. After a 
3-week treatment with albendazole, he has remained symp-
tom-free with no further relapses for 2 years. His most recent 
eosinophil count was 188 cells/μL (Fig. 4).
DISCUSSION
Since the first report of human toxocariasis in the 1950s, toxo-
cariasis has become the most prevalent helminthiasis in indus-
trialized countries.
1,3 In 2002, Park et al.
2 reported that the sero-
prevalence of toxocariasis in Korean rural adults was approxi-
mately 5%, based on research in Gangwon province. After in-
gestion as embryonated eggs or adults, Toxocara can live in the 
small intestine of dogs or cats. Eggs escape the intestine through 
defecation and become embryonated while resting on or in the 
soil. Humans may ingest the eggs accidentally through contact 
with pet feces, eating contaminated raw vegetables, or consum-
ing raw meat from a paratenic host.
1,3 The patient described 
here most likely contracted toxocariasis as a result of consum-
ing raw cow liver (not raw fish); it has been reported that a re-
cent history of eating raw cow liver is related to increased risk 
for toxocariasis in patients with eosinophilia of unknown etiol-
ogy in Korea.
4
Although Toxocara eggs may hatch in the human small intes-
tine, larvae cannot develop into adults in humans and thus re-
main in a juvenile stage.
1,3 Larvae then penetrate the intestinal 
wall and migrate to multiple organs via the blood stream; di-
verse clinical features may develop according to the involved or-
gan.
1,3 Toxocariasis is classified as visceral larva migrans (VLM) 
when it involves the major organs, or ocular larva migrans when 
it involves the eye and optic nerve.
1,3 The patient described here 
demonstrated the clinical features of VLM: abdominal pain, eo-
sinophilia, pulmonary focal ground-glass opacities, and hepatic 
eosinophilic abscess. Immediate hypersensitivity to dying or 
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dead larvae in organs may also elicit fever, enlargement of the 
liver or spleen, lower respiratory symptoms resembling asthma, 
hypergammaglobulinemia, myocarditis, nephritis, central ner-
vous system involvement, and other conditions.
1,3 In the pres-
ent case, the patient complained of abdominal pain in the first 
attack, urticaria during the second attack, and abdominal pain 
again during the third attack.
Many studies have reported an association between chronic 
urticaria and toxocariasis,
5,6 but few reports describe acute urti-
caria, particularly in association with recurrent disease.
6 Although 
skin lesions are rarely the only symptom of toxocariasis, previ-
ous studies and the case described here demonstrate that urti-
caria may be a sign of toxocariasis or other parasitic infections.
6 
Although we initially considered the possibility of anisakiasis, 
we excluded this condition because the patient had not recent-
ly consumed raw fish and because gastroscopy showed no phys-
ical evidence of the parasite. Instead, the patient was diagnosed 
with toxocariasis based on the detection of T. canis E/S antigens 
at a high titer. However, given that immunodiagnostic tests can-
not discriminate between current and past infections, it is im-
portant to determine the blood eosinophil count and serum to-
tal IgE together when recurrence is suspected.
1
Recurrent disease was resolved through prolonged albenda-
zole treatment. Albendazole is the treatment of choice for toxo-
cariasis, with a currently recommended regimen of 10 mg/kg/
day in two doses (400 mg twice daily) for 5 days.
1,3 Interestingly, 
recent clinical studies have shown that relatively few patients, 
only 6 of 19 (32%), are cured after 5-day albendazole therapy.
7,8 
Instead, in Japan, adults who contract toxocariasis (typically 
through eating raw liver) are treated with albendazole for 4 weeks 
or longer.
7,9 Accordingly, further study is required to reach a 
consensus regarding the appropriate duration of albendazole 
therapy to eliminate toxocariasis.
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